The clinical trials below are available in the specialty you selected. Choose a different specialty.
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Staggered, Single and Multiple Ascending Dose, Multicenter Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 in Subjects with Moderate to Severe Ulcerative Colitis
Men and women between the ages of 18 & 65 with a diagnosis of ulcerative colitis may participate in a research study for an investigational drug, which has been developed as a potential therapy to reduce the inflammation and tissue damage associated with a colitis flare without suppressing the patient's immune system. (REF# 00048410)
Baminercept in Sjögren’s Syndrome
We are seeking participants who are between 18 and 75 years of age and have a diagnosis of primary Sjögren’s syndrome, and are bothered by dry eyes, dry mouth, joint pain and fatigue. (REF# 33911)